To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 13, 2021)
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.
What just happenedMay 14, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMay 13, 2021
- May 14, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 13, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 13, 2021IntroReferralIntro-H
Introduced in House
- May 13, 2021IntroReferral1000
Introduced in House